APA

Takahashi H., Riether D., Bartolozzi A., Bosanac T., Berger V., Binetti R., Broadwater J., Chen Z., Crux R., De Lombaert S., Dave R., Dines J. A., Fadra-Khan T., Flegg A., Garrigou M., Hao M., Huber J., Hutzler J. M., Kerr S., Kotey A., Liu W., Lo H. Y., Loke P. L., Mahaney P. E., Morwick T. M., Napier S., Olague A., Pack E., Padyana A. K., Thomson D. S., Tye H., Wu L., Zindell R. M., Abeywardane A. & Simpson T. (20150507). Synthesis, SAR, and series evolution of novel oxadiazole-containing 5-lipoxygenase activating protein inhibitors: discovery of 2-[4-(3-{(r)-1-[4-(2-amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915). : Journal of medicinal chemistry.

Chicago

Takahashi Hidenori, Riether Doris, Bartolozzi Alessandra, Bosanac Todd, Berger Valentina, Binetti Ralph, Broadwater John, Chen Zhidong, Crux Rebecca, De Lombaert Stéphane, Dave Rajvee, Dines Jonathon A, Fadra-Khan Tazmeen, Flegg Adam, Garrigou Michael, Hao Ming-Hong, Huber John, Hutzler J Matthew, Kerr Steven, Kotey Adrian, Liu Weimin, Lo Ho Yin, Loke Pui Leng, Mahaney Paige E, Morwick Tina M, Napier Spencer, Olague Alan, Pack Edward, Padyana Anil K, Thomson David S, Tye Heather, Wu Lifen, Zindell Renee M, Abeywardane Asitha and Simpson Thomas. 20150507. Synthesis, SAR, and series evolution of novel oxadiazole-containing 5-lipoxygenase activating protein inhibitors: discovery of 2-[4-(3-{(r)-1-[4-(2-amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915). : Journal of medicinal chemistry.

Harvard

Takahashi H., Riether D., Bartolozzi A., Bosanac T., Berger V., Binetti R., Broadwater J., Chen Z., Crux R., De Lombaert S., Dave R., Dines J. A., Fadra-Khan T., Flegg A., Garrigou M., Hao M., Huber J., Hutzler J. M., Kerr S., Kotey A., Liu W., Lo H. Y., Loke P. L., Mahaney P. E., Morwick T. M., Napier S., Olague A., Pack E., Padyana A. K., Thomson D. S., Tye H., Wu L., Zindell R. M., Abeywardane A. and Simpson T. (20150507). Synthesis, SAR, and series evolution of novel oxadiazole-containing 5-lipoxygenase activating protein inhibitors: discovery of 2-[4-(3-{(r)-1-[4-(2-amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915). : Journal of medicinal chemistry.

MLA

Takahashi Hidenori, Riether Doris, Bartolozzi Alessandra, Bosanac Todd, Berger Valentina, Binetti Ralph, Broadwater John, Chen Zhidong, Crux Rebecca, De Lombaert Stéphane, Dave Rajvee, Dines Jonathon A, Fadra-Khan Tazmeen, Flegg Adam, Garrigou Michael, Hao Ming-Hong, Huber John, Hutzler J Matthew, Kerr Steven, Kotey Adrian, Liu Weimin, Lo Ho Yin, Loke Pui Leng, Mahaney Paige E, Morwick Tina M, Napier Spencer, Olague Alan, Pack Edward, Padyana Anil K, Thomson David S, Tye Heather, Wu Lifen, Zindell Renee M, Abeywardane Asitha and Simpson Thomas. Synthesis, SAR, and series evolution of novel oxadiazole-containing 5-lipoxygenase activating protein inhibitors: discovery of 2-[4-(3-{(r)-1-[4-(2-amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915). : Journal of medicinal chemistry. 20150507.